Screener
CytomX Therapeutics CTMX Depreciation And Amortization Excluding Amortization Of Intangible Assets
Depreciation And Amortization Excluding Amortization Of Intangible Assets at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept ctmx:DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's depreciation and amortization excluding amortization of intangible assets?
- CytomX Therapeutics (CTMX) reported depreciation and amortization excluding amortization of intangible assets of $11K in Q2 2026.
- How has CytomX Therapeutics's depreciation and amortization excluding amortization of intangible assets changed year-over-year?
- CytomX Therapeutics's depreciation and amortization excluding amortization of intangible assets decreased by 96.5% year-over-year, from $310K to $11K.
- What is the long-term trend for CytomX Therapeutics's depreciation and amortization excluding amortization of intangible assets?
- Over 4 years (2021 to 2025), CytomX Therapeutics's depreciation and amortization excluding amortization of intangible assets has grown at a -16.7% compound annual growth rate (CAGR), from $2.56M to $1.23M.
- What does depreciation and amortization excluding amortization of intangible assets mean?
- Depreciation And Amortization Excluding Amortization Of Intangible Assets as reported by CytomX Therapeutics, Inc..
Ask your AI about CytomX Therapeutics's depreciation and amortization excluding amortization of intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude